One of the doctors behind the Sandler-Kenner Foundation discusses the importance of this finding.
Irving, TX, June XX, 2015 – As researchers work around the clock to find better treatments and a cure for pancreatic cancer, a breakthrough in the possible prevention of this disease has been found. With an estimated 44,000 new cases diagnosed annually, pancreatic cancer isn’t the most prevalent form of cancer in the country, but it’s among the deadliest forms of the disease courtesy of a very low survivability rate. Research is now showing, however, that vitamin D may give people an edge in the prevention of this form of cancer.
“The findings come from several studies that indicate a robust level of vitamin D may serve as a strong preventative for this often fatal disease,” says Dr. Gregory Echt, one of the physicians behind the Sandler-Kenner Foundation and the founder and lead surgeon at Choice Cancer Care. “This is incredibly significant in furthering the understanding of this disease.”
One of the studies was conducted at the Harvard Medical School. There researchers found individuals who took a higher dose of vitamin D on a regular basis has a 40 percent lower chance of developing pancreatic cancer than their counterparts who did not. Another study from the University of California reviewed data from 107 countries. That research found the highest pancreatic cancer rates originated in countries where the least amount of sunlight was available.
Vitamin D is known to help block the growth of cancer cells. Researchers say it is possible it may also help reduce risks of other cancers, including colon and breast.
“While it’s not possible to prevent every pancreatic cancer case, research may help us gain an edge against this disease,” says Dr. Echt. “Anyone who is concerned should discuss it and potential preventative measures with their healthcare providers."
About Sandler-Kenner Foundation:-
Established in 2007, the Sandler-Kenner Foundation is a 501(c)(3) charitable organization with a focus on raising awareness of pancreatic cancer and improving survival rates by supporting advancement in the tools used to detect and diagnose the disease.
For more information about the Sandler-Kenner Foundation or to